Atea Pharmaceuticals Inc (AVIR)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Assets | 694.34M | 686.58M | 666.71M | 638.13M | 626.03M | 608.08M | 594.97M | 553.03M |
Total Current Assets | 689.45M | 681.94M | 660.92M | 632.39M | 620.83M | 603.32M | 590.46M | 548.76M |
Cash and Equivalents | 684.48M | 176.41M | 188.46M | 183.26M | 213.7M | 137.89M | 143.82M | 160.91M |
Total Non-Current Assets | 4.89M | 4.64M | 5.1M | 7.34M | 5.2M | 4.76M | 5.8M | 5.45M |
Total Liabilities | 33.88M | 23.39M | 26.14M | 19.95M | 23.68M | 26.35M | 39.78M | 48.66M |
Total Current Liabilities | 25.11M | 15.63M | 18.48M | 12.36M | 16.16M | 18.89M | 32.38M | 41.31M |
Total Non-Current Liabilities | 8.77M | 7.76M | 7.66M | 7.59M | 7.52M | 7.45M | 7.4M | 7.35M |
Common Equity | 83k | 83k | 83k | 83k | 83k | 83k | 83k | 84k |
Retained Earnings | -17.38M | -25.45M | -59.88M | -95.35M | -123.53M | -156.67M | -195.84M | -259M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 22.07M | 863.63M | 772.89M | 666.71M | 594.97M |
Total Current Assets | 21.91M | 863.48M | 772.4M | 660.92M | 590.46M |
Cash and Equivalents | 21.66M | 850.12M | 764.38M | 188.46M | 143.82M |
Total Non-Current Assets | -49.57M | 547.8M | 710.08M | 640.57M | 555.19M |
Total Liabilities | 2.53M | 315.83M | 62.82M | 26.14M | 39.78M |
Total Current Liabilities | 2.44M | 315.8M | 56.88M | 18.48M | 32.38M |
Total Non-Current Liabilities | 95k | 36k | 5.93M | 7.66M | 7.4M |
Total Equity | -49.57M | 547.8M | 710.08M | 640.57M | 555.19M |
Common Equity | 10k | 82k | 83k | 83k | 83k |
Retained Earnings | -54.21M | -65.16M | 56.03M | -59.88M | -195.84M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.